Robin and Jeannie discuss the success of the regenerative medicine initiative, highlighting the FDA approved therapeutics, breakthroughs, and fast track therapeutics that were developed. They also mention the additional funding, job creation, and revenue brought to California. The conversation emphasizes the impact of expediting bench to bedside research and the potential for curing previously incurable diseases.
